IL‐25 promotes cisplatin resistance of lung cancer cells by activating NF‐κB signaling pathway to increase of major vault protein
Abstract As an inflammatory factor, IL‐25 has been studied in variouscancers, but it is rarely reported in cancer chemotherapy resistance. Major vault protein (MVP), as a gene associated with lung multidrug resistance, is associated with multiple chemotherapy resistances of lung cancer. However, the...
Main Authors: | Weiming Shen, Yang Qiu, Jingyao Li, Chao Wu, Zhihui Liu, Xiaorong Zhang, Xiaohong Hu, Yi Liao, Haidong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-07-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2213 |
Similar Items
-
Cisplatin Induced Nephrotoxicity
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2014-02-01) -
CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma
by: Lin J, et al.
Published: (2021-01-01) -
The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy
by: Gianni Frascotti, et al.
Published: (2021-02-01) -
Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer
by: Pramod Kumar Gupta, et al.
Published: (2016-01-01) -
MVC SOFTWARE ARCHITECTURE PATTERN FOR WEB-APPLICATION OF SYSTEM OF MONITORING OF AIRPORT TRANSPORT
by: B. P. Eliseev, et al.
Published: (2016-11-01)